RADIOGRAPHY); The deadline for the lead applicant is August 1, 2022

PHILADELPHIA CREAM, June 10, 2022 /PRNewswire/ — Shepherd Montague is investigating allegations of securities fraud on behalf of investors who purchased Dentsply Sirona, Inc. (“Dentsply” or the “Company”) (NASDAQ: XRAY) securities between June 9, 2021 and May 9, 2022 (the “Class Period”).

If you purchased Dentsply securities during the Class Period, would like to discuss At Berger Montague investigation, or if you have any questions regarding your rights or interests, please contact the lawyers Andre Abramowitz at [email protected] or (215) 875-3015, or Michael Dell‘Angelo to [email protected] or (215) 875-3080 or visit: https://investigations.bergermontague.com/dentsply-sirona/

Whistleblowers: Anyone with non-public information about Dentsply is encouraged to help confidentially. At Berger Montague survey or take advantage of the SEC Whistleblower program. Under this program, whistleblowers who provide original information may receive rewards totaling up to thirty percent (30%) of recoveries obtained by the SEC. For more information, contact us.

Dentsply is a dental equipment manufacturer that produces a wide range of dental supplies, ranging from anesthetics, plaque and gum disease prevention, tooth polishers and artificial teeth.

The complaint alleges that, throughout the class action period, the defendants orchestrated a scheme to inflate the company’s revenues and profits by manipulating its accounting for a distributor rebate program to qualify senior executives. significant cash and stock incentive compensation.

The truth about Dentsply’s misconduct was revealed in a series of revelations, beginning on April 19, 2022when Dentsply announced the sudden departure of its CEO.

On May 10, 2022Dentsply announced that, following reports from several whistleblowers, its board’s audit committee has opened an internal investigation into certain financial reporting matters, including “the company’s use of incentives to sell products to distributors during the third and fourth quarters of 2021” and whether “certain former and current executive officers have directed the Company’s use of these incentives and other actions to achieve the objectives of executive compensation in 2021”.

As a result of these disclosures, Dentsply’s stock price fell significantly and investors suffered heavy losses.

Shepherd Montaguewith offices at philadelphia cream, Minneapolis, washington d.c.and San Diegohas been a pioneer in securities class actions since its founding in 1970. Shepherd Montague has represented individual and institutional investors for over five decades and acts as lead counsel before courts across United States.

contacts
Andre Abramowitzsenior counsel
Shepherd Montague
(215) 875-3015
[email protected]

Michael Dell‘Angelo, executive shareholder
Shepherd Montague
(215) 875-3080
[email protected]

THE SOURCE Shepherd Montague

Karen J. Nelson